Sign inJoin waitlistJoin the waitlist

Adam Frymoyer

Clinical Assistant Professor, Pediatrics · Stanford Health Care

Credentials: · ·

History

University of California-San Francisco
2007–2010
University of California-San Francisco
2004–2007

Research

Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?
Review · Clinical Pharmacology & Therapeutics · 2012 · 258 citations
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer
Review · Frontiers in Immunology · 2015 · 225 citations
Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development
Molecular Pharmaceutics · 2013 · 164 citations

Valerie Chock
12 papers
Adam Hersh
9 papers
David Drover
8 papers
Felice Su
7 papers
Paul Bollyky
7 papers
Arun Gupta
6 papers
Janelle Aby
6 papers
Neha Joshi
6 papers · 2 as a resident
Sonia Bonifacio
6 papers
Juliann Kim
5 papers
Krisa Van Meurs
5 papers
RC
Ronald Cohen
5 papers

Grants

Pharmacology of Aminophylline for Acute Kidney Injury in Neonates and Children
National Institute of Child Health and Human Development · K23
Contact PI · $732K · Stanford University
2014–2019

Clinical trials

Pharmacology of Aminophylline for Acute Kidney Injury in Neonates
Principal investigator · Terminated
Stanford University
2014–2018
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Principal investigator · Completed · Phase 1
Uptal Patel
2012–2013
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Sub-investigator · Recruiting · Phase 1
Stanford University
2022–2026